Work

A phase II study of pembrolizumab and docetaxel for aggressive RAI refractory thyroid carcinomas or salivary gland cancers: The iPRIME study.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps6099

Authors: Tanguy Y. Seiwert, Jonas A. De Souza, Everett E. Vokes, Nishant Agrawal

Institutions: University of Chicago, Johns Hopkins University

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889831063

Cites:

Cited by: 3

Related to: 10